CVS Health 3Q 2026: Revenue $108.4B, EPS $1.68— 10-Q Summary

What happened

CVS Health reported third-quarter 2026 revenue of $108.4 billion, up 5.4% from a year earlier, and net income of $2.17 billion versus a prior-year loss. Diluted earnings per share were $1.68. The company plans to separate into healthcare solutions and retail pharmacy and community healthcare companies by the first half of 2028.

Confirmed

Global impact / market context

The results show growth in Health Care Benefits and Health Services, but Pharmacy & Consumer Wellness revenue fell amid drug price reductions and reimbursement pressure. That divergence matters because reimbursement and pricing can shape revenue and profit per sale across CVS’s businesses; the planned separation could change how investors assess them.

Analyst inference

Revenue rose 5.4% year over year, while net income moved from a prior-year loss to a profit. Business performance was mixed: Health Services grew 9.5%, but Pharmacy & Consumer Wellness declined 2.0%. The reported figures provide a baseline for judging future operating results and separation progress.

Analyst inference

What to watch

1. Watch whether Health Care Benefits sustains growth and whether its medical benefit ratio, the share of premiums used for medical care, remains improved from the reported 91.3%. Analyst inference
2. Track whether Pharmacy & Consumer Wellness revenue stabilizes as drug price reductions and reimbursement pressure continue, especially alongside prescription volume growth of 1.9%. Analyst inference
3. Look for updates on the planned separation into healthcare solutions and retail pharmacy and community healthcare companies, including progress toward the first-half 2028 target. Proposed

Evidence

• Original source link unavailable